Literature DB >> 12706990

Microbial virulence results from the interaction between host and microorganism.

Arturo Casadevall, Liise-anne Pirofski.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12706990     DOI： 10.1016/s0966-842x(03)00008-8

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN： 0966-842X            Impact factor:   17.079


× No keyword cloud information.
  11 in total

1.  Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier.

Authors:  Caroline Charlier; Fabrice Chrétien; Marielle Baudrimont; Elodie Mordelet; Olivier Lortholary; Françoise Dromer
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

2.  Interaction of Candida albicans with adherent human peripheral blood mononuclear cells increases C. albicans biofilm formation and results in differential expression of pro- and anti-inflammatory cytokines.

Authors:  Jyotsna Chandra; Thomas S McCormick; Yoshifumi Imamura; Pranab K Mukherjee; Mahmoud A Ghannoum
Journal:  Infect Immun       Date:  2007-03-05       Impact factor: 3.441

3.  Redirecting the humoral immune response against Streptococcus mutans antigen P1 with monoclonal antibodies.

Authors:  Monika W Oli; Nikki Rhodin; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

4.  Use of a genetically engineered strain to evaluate the pathogenic potential of yeast cell and filamentous forms during Candida albicans systemic infection in immunodeficient mice.

Authors:  Stephen P Saville; Anna L Lazzell; Ashok K Chaturvedi; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

Review 5.  Targeting Candida albicans filamentation for antifungal drug development.

Authors:  Taissa Vila; Jesus A Romo; Christopher G Pierce; Stanton F McHardy; Stephen P Saville; José L Lopez-Ribot
Journal:  Virulence       Date:  2016-06-07       Impact factor: 5.882

Review 6.  Candidiasis drug discovery and development: new approaches targeting virulence for discovering and identifying new drugs.

Authors:  Christopher G Pierce; Jose L Lopez-Ribot
Journal:  Expert Opin Drug Discov       Date:  2013-06-06       Impact factor: 6.098

7.  Effects of surfactant protein-A on the interaction of Pneumocystis murina with its host at different stages of the infection in mice.

Authors:  Michael J Linke; Alan A Ashbaugh; Judith V Koch; Linda Levin; Reiko Tanaka; Peter D Walzer
Journal:  J Eukaryot Microbiol       Date:  2009 Jan-Feb       Impact factor: 3.346

8.  Commensal microbiota is fundamental for the development of inflammatory pain.

Authors:  F A Amaral; D Sachs; V V Costa; C T Fagundes; D Cisalpino; T M Cunha; S H Ferreira; F Q Cunha; T A Silva; J R Nicoli; L Q Vieira; D G Souza; M M Teixeira
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-11       Impact factor: 11.205

9.  Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates.

Authors:  Suélen A Rossi; Nuria Trevijano-Contador; Liliana Scorzoni; Ana Cecilia Mesa-Arango; Haroldo C de Oliveira; Karin Werther; Tânia de Freitas Raso; Maria J S Mendes-Giannini; Oscar Zaragoza; Ana M Fusco-Almeida
Journal:  Front Microbiol       Date:  2016-02-16       Impact factor: 5.640

10.  Host genotype and environment affect the trade-off between horizontal and vertical transmission of the parasite Edhazardia aedis.

Authors:  Giacomo Zilio; Kevin Thiévent; Jacob C Koella
Journal:  BMC Evol Biol       Date:  2018-04-24       Impact factor: 3.260
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.